on 25 Oct 2023
Last Applicant/ Owned by
Anagram Therapeutics, Inc.
10 Speen Street, Suite 302
Framingham, Massachusetts, 01701
Serial Number
UK00003971680 filed on 25th Oct 2023
Registration Number
UK00003971680 registered on
2th Feb 2024
Correspondent Information
Barker Brettell LLP
100 Hagley Road, Edgbaston
Birmingham,
B16 8QQ
Pharmaceutical preparations for the treatment of malabsorption syndromes, nutrient metabolism disorders, rare diseases, congenital disorders, pancreatic diseases and disorders, gastrointestinal diseases and disorders, metabolic diseases and disorders and inflammatory diseases and disorders.
Research and development in the field of oral enzyme therapies; pharmaceutical research and development services; providing scientific research information in the field of pharmaceuticals, oral enzyme therapies, and clinical trials; research and development of pharmaceuticals and therapeutics for the treatment of malabsorption syndromes, nutrient metabolism disorders, rare diseases, congenital disorders, pancreatic diseases and disorders, gastrointestinal diseases and disorders, metabolic diseases and disorders and inflammatory diseases and disorders.
UK00003971680
Word
Individual